Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency

Hironori Nagasaka, Tohru Yorifuji, Hiroto Egawa, Ayano Inui, Tomoo Fujisawa, Haruki Komatsu, Hirokazu Tsukahara, Shinji Uemoto, Yukihiro Inomata

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Urea cycle deficient patients with prominent hyperammonemic often exhibit abnormal production of nitric oxide (NO), which reduces vascular tone, along with amino acid abnormalities. However, information related to the metabolic changes in heterozygotes of ornithine transcarbamylase deficiency (OTCD) lacking overt hyperammonemia is quite limited. We examined vascular mediators and amino acids in non-hyperammonemic heterozygotes. Twenty-four heterozygous OTCD adult females without hyperammonemic bouts, defined as non-hyperammonemic carriers, were enrolled. Wemeasured blood amino acids constituting urea cycle and nitric oxide (NO) cycle. Blood concentrations of nitrate/nitrite (NOx) as stable NO-metabolites, asymmetric dimethylarginine (ADMA) inhibiting NO synthesis, and endothelin-1 (ET-1) raising vascular tone were also determined. NOx concentrations were significantly lower in non-hyperammonemic carriers (p <0.01). However, ADMA and ET-1 levels in this groupwere comparable to those in the age-matched control group. Arginine and citrulline levelswere also significantly lower in non-hyperammonemic carriers than in controls (p <0.01). Of the 24 non-hyperammonemic carriers, 10 often developed headaches. Their daily NOx and arginine levels were significantly lower than those in headache-free carriers (p <0.05). In three carriers receiving oral L-arginine, blood NOx concentrations were significantly higher. In two of those three, the occurrence of headaches was decreased. These results suggest that NO cycle coupling with the urea cycle is altered substantially even in nonhyperammonemic OTCD carriers, predisposing them to headaches.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalMolecular Genetics and Metabolism
Volume109
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Ornithine Carbamoyltransferase Deficiency Disease
Ornithine Carbamoyltransferase
Urea
Nitric Oxide
Headache
Blood Vessels
Arginine
Blood
Endothelin-1
Heterozygote
Amino Acids
Hyperammonemia
Citrulline
Metabolites
Nitrites
Nitrates
Research Design
Control Groups

Keywords

  • Carriers
  • Nitric oxide-citrulline cycle
  • Ornithine transcarbamylase deficiency
  • Urea cycle

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency. / Nagasaka, Hironori; Yorifuji, Tohru; Egawa, Hiroto; Inui, Ayano; Fujisawa, Tomoo; Komatsu, Haruki; Tsukahara, Hirokazu; Uemoto, Shinji; Inomata, Yukihiro.

In: Molecular Genetics and Metabolism, Vol. 109, No. 3, 2013, p. 251-254.

Research output: Contribution to journalArticle

Nagasaka, Hironori ; Yorifuji, Tohru ; Egawa, Hiroto ; Inui, Ayano ; Fujisawa, Tomoo ; Komatsu, Haruki ; Tsukahara, Hirokazu ; Uemoto, Shinji ; Inomata, Yukihiro. / Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency. In: Molecular Genetics and Metabolism. 2013 ; Vol. 109, No. 3. pp. 251-254.
@article{05dd88bb545948d4918fadfb9adfd9a4,
title = "Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency",
abstract = "Urea cycle deficient patients with prominent hyperammonemic often exhibit abnormal production of nitric oxide (NO), which reduces vascular tone, along with amino acid abnormalities. However, information related to the metabolic changes in heterozygotes of ornithine transcarbamylase deficiency (OTCD) lacking overt hyperammonemia is quite limited. We examined vascular mediators and amino acids in non-hyperammonemic heterozygotes. Twenty-four heterozygous OTCD adult females without hyperammonemic bouts, defined as non-hyperammonemic carriers, were enrolled. Wemeasured blood amino acids constituting urea cycle and nitric oxide (NO) cycle. Blood concentrations of nitrate/nitrite (NOx) as stable NO-metabolites, asymmetric dimethylarginine (ADMA) inhibiting NO synthesis, and endothelin-1 (ET-1) raising vascular tone were also determined. NOx concentrations were significantly lower in non-hyperammonemic carriers (p <0.01). However, ADMA and ET-1 levels in this groupwere comparable to those in the age-matched control group. Arginine and citrulline levelswere also significantly lower in non-hyperammonemic carriers than in controls (p <0.01). Of the 24 non-hyperammonemic carriers, 10 often developed headaches. Their daily NOx and arginine levels were significantly lower than those in headache-free carriers (p <0.05). In three carriers receiving oral L-arginine, blood NOx concentrations were significantly higher. In two of those three, the occurrence of headaches was decreased. These results suggest that NO cycle coupling with the urea cycle is altered substantially even in nonhyperammonemic OTCD carriers, predisposing them to headaches.",
keywords = "Carriers, Nitric oxide-citrulline cycle, Ornithine transcarbamylase deficiency, Urea cycle",
author = "Hironori Nagasaka and Tohru Yorifuji and Hiroto Egawa and Ayano Inui and Tomoo Fujisawa and Haruki Komatsu and Hirokazu Tsukahara and Shinji Uemoto and Yukihiro Inomata",
year = "2013",
doi = "10.1016/j.ymgme.2013.04.013",
language = "English",
volume = "109",
pages = "251--254",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency

AU - Nagasaka, Hironori

AU - Yorifuji, Tohru

AU - Egawa, Hiroto

AU - Inui, Ayano

AU - Fujisawa, Tomoo

AU - Komatsu, Haruki

AU - Tsukahara, Hirokazu

AU - Uemoto, Shinji

AU - Inomata, Yukihiro

PY - 2013

Y1 - 2013

N2 - Urea cycle deficient patients with prominent hyperammonemic often exhibit abnormal production of nitric oxide (NO), which reduces vascular tone, along with amino acid abnormalities. However, information related to the metabolic changes in heterozygotes of ornithine transcarbamylase deficiency (OTCD) lacking overt hyperammonemia is quite limited. We examined vascular mediators and amino acids in non-hyperammonemic heterozygotes. Twenty-four heterozygous OTCD adult females without hyperammonemic bouts, defined as non-hyperammonemic carriers, were enrolled. Wemeasured blood amino acids constituting urea cycle and nitric oxide (NO) cycle. Blood concentrations of nitrate/nitrite (NOx) as stable NO-metabolites, asymmetric dimethylarginine (ADMA) inhibiting NO synthesis, and endothelin-1 (ET-1) raising vascular tone were also determined. NOx concentrations were significantly lower in non-hyperammonemic carriers (p <0.01). However, ADMA and ET-1 levels in this groupwere comparable to those in the age-matched control group. Arginine and citrulline levelswere also significantly lower in non-hyperammonemic carriers than in controls (p <0.01). Of the 24 non-hyperammonemic carriers, 10 often developed headaches. Their daily NOx and arginine levels were significantly lower than those in headache-free carriers (p <0.05). In three carriers receiving oral L-arginine, blood NOx concentrations were significantly higher. In two of those three, the occurrence of headaches was decreased. These results suggest that NO cycle coupling with the urea cycle is altered substantially even in nonhyperammonemic OTCD carriers, predisposing them to headaches.

AB - Urea cycle deficient patients with prominent hyperammonemic often exhibit abnormal production of nitric oxide (NO), which reduces vascular tone, along with amino acid abnormalities. However, information related to the metabolic changes in heterozygotes of ornithine transcarbamylase deficiency (OTCD) lacking overt hyperammonemia is quite limited. We examined vascular mediators and amino acids in non-hyperammonemic heterozygotes. Twenty-four heterozygous OTCD adult females without hyperammonemic bouts, defined as non-hyperammonemic carriers, were enrolled. Wemeasured blood amino acids constituting urea cycle and nitric oxide (NO) cycle. Blood concentrations of nitrate/nitrite (NOx) as stable NO-metabolites, asymmetric dimethylarginine (ADMA) inhibiting NO synthesis, and endothelin-1 (ET-1) raising vascular tone were also determined. NOx concentrations were significantly lower in non-hyperammonemic carriers (p <0.01). However, ADMA and ET-1 levels in this groupwere comparable to those in the age-matched control group. Arginine and citrulline levelswere also significantly lower in non-hyperammonemic carriers than in controls (p <0.01). Of the 24 non-hyperammonemic carriers, 10 often developed headaches. Their daily NOx and arginine levels were significantly lower than those in headache-free carriers (p <0.05). In three carriers receiving oral L-arginine, blood NOx concentrations were significantly higher. In two of those three, the occurrence of headaches was decreased. These results suggest that NO cycle coupling with the urea cycle is altered substantially even in nonhyperammonemic OTCD carriers, predisposing them to headaches.

KW - Carriers

KW - Nitric oxide-citrulline cycle

KW - Ornithine transcarbamylase deficiency

KW - Urea cycle

UR - http://www.scopus.com/inward/record.url?scp=84891372955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891372955&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2013.04.013

DO - 10.1016/j.ymgme.2013.04.013

M3 - Article

C2 - 23669167

AN - SCOPUS:84891372955

VL - 109

SP - 251

EP - 254

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -